
|Articles|October 15, 2004
Large RCC database answers key prognostic questions
Los Angeles--The largest clinical database built on renal cell carcinoma is beginning to yield definitive answers to questions about prognosis and treatment. Analyses of histories of more than 4,000 patients at eight academic medical centers worldwide has already indicated that tumor stage, grade, and performance status have a stronger influence on prognosis than tumor stage alone and that the indications for partial nephrectomy can expand.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Urologist describes early experience with gemcitabine intravesical system in NMIBC
2
Ronney Abaza, MD, discusses the next wave of advancements in robotic surgery
3
Ravi Chauhan, MD, discusses integrating nadofaragene into clinical practice
4
Brooke Edwards, MD, offers advice on growing your ASC
5




















